BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38250075)

  • 21. Adult-onset eosinophilic airway diseases.
    Asano K; Ueki S; Tamari M; Imoto Y; Fujieda S; Taniguchi M
    Allergy; 2020 Dec; 75(12):3087-3099. PubMed ID: 33040364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatments of refractory eosinophilic lung diseases with biologics.
    Asano K; Suzuki Y; Tanaka J; Kobayashi K; Kamide Y
    Allergol Int; 2023 Jan; 72(1):31-40. PubMed ID: 36333218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    Olaguibel JM; Sastre J; Rodríguez JM; Del Pozo V
    J Investig Allergol Clin Immunol; 2022 Jun; 32(3):165-180. PubMed ID: 35522053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
    BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome.
    Pouliquen IJ; Austin D; Steinfeld J; Yancey SW
    Clin Ther; 2021 Jul; 43(7):1278-1280. PubMed ID: 34187697
    [No Abstract]   [Full Text] [Related]  

  • 26. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
    Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
    BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disorders.
    Makiya MA; Khoury P; Kuang FL; Mata AD; Mahmood S; Bowman A; Espinoza D; Kovacs N; Brown T; Holland N; Wetzler L; Ware JM; Dyer AM; Akuthota P; Bochner BS; Chinchilli VM; Gleich GJ; Langford C; Merkel PA; Specks U; Weller PF; Wechsler ME; Prussin C; Fay MP; Klion AD
    Allergy; 2023 Jan; 78(1):258-269. PubMed ID: 35971862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologics for eosinophilic granulomatosis with polyangiitis.
    Caminati M; Maule M; Bello F; Emmi G
    Curr Opin Allergy Clin Immunol; 2023 Feb; 23(1):36-43. PubMed ID: 36413432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis.
    Higashitani K; Yoshimi R; Sato Y; Watanabe T; Ihata A
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):87-92. PubMed ID: 34473835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence.
    Caminati M; Micheletto C; Norelli F; Olivieri B; Ottaviano G; Padoan R; Piacentini G; Schiappoli M; Senna G; Menzella F
    Expert Opin Biol Ther; 2024; 24(1-2):15-23. PubMed ID: 38197326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review.
    Wu EY; Hernandez ML; Jennette JC; Falk RJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1496-1504. PubMed ID: 30197069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab.
    Tsioulos G; Kounatidis D; Vallianou NG; Koufopoulos N; Katsimbri P; Antoniadou A
    Am J Med Sci; 2023 Jan; 365(1):93-98. PubMed ID: 35970248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: Middle lobe syndrome: a rare presentation in eosinophilic granulomatosis with polyangiitis.
    Maranini B; Guzzinati I; Casoni GL; Ballotta M; Lo Monaco A; Govoni M
    Front Immunol; 2023; 14():1222431. PubMed ID: 37638004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management.
    Mahr A; Moosig F; Neumann T; Szczeklik W; Taillé C; Vaglio A; Zwerina J
    Curr Opin Rheumatol; 2014 Jan; 26(1):16-23. PubMed ID: 24257370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
    Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
    Ahn SS; Yoo J; Park YB; Park JW; Lee JH; Lee SW
    Asian Pac J Allergy Immunol; 2023 Sep; 41(3):244-252. PubMed ID: 33068368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault C; Pagnoux C; Jayne D; Guillevin L; Cordier JF;
    Autoimmun Rev; 2017 Jan; 16(1):1-9. PubMed ID: 27671089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophil-associated diseases: the allergist's and clinical immunologist's perspective.
    Marra AM; Rossi CM; Piga MA; Moroncini G; Bilò MB
    Eur Ann Allergy Clin Immunol; 2024 Mar; ():. PubMed ID: 38546414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophilic Lung Diseases.
    Cottin V
    Immunol Allergy Clin North Am; 2023 May; 43(2):289-322. PubMed ID: 37055090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.